(ST125) Genomic landscape of ERBB2 alterations in solid tumors without an approved HER2-targeted therapy

Saturday, November 18, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Rebecca A. Previs, dR (she/her/hers)

Director of Medical Affairs
Labcorp Oncology, Duke University Medical Center
Chapel Hill, North Carolina, United States